AA
BIIB icon

Auxano Advisors’s Biogen BIIB Stock Holding History

Auxano Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,321
Closed -$450K – 163
2024
Q3 		$450K Sell
2,321
-257
-10% -$53.8K 0.12% 100
2024
Q2 		$598K Sell
2,578
-62
-2% -$13.5K 0.17% 88
2024
Q1 		$569K Buy
2,640
+444
+20% +$104K 0.17% 88
2023
Q4 		$568K Buy
2,196
+20
+0.9% +$4.91K 0.19% 80
2023
Q3 		$559K Buy
2,176
+7
+0.3% +$1.87K 0.23% 61
2023
Q2 		$603K Hold
2,169
– – 0.24% 55
2023
Q1 		$603K Buy
2,169
+108
+5% +$29.9K 0.24% 55
2022
Q4 		$571K Sell
2,061
-67
-3% -$18.9K 0.26% 56
2022
Q3 		$568K Buy
2,128
+723
+51% +$154K 0.26% 52
2022
Q2 		$287K Buy
1,405
+404
+40% +$82.6K 0.14% 65
2022
Q1 		$211K Buy
1,001
+100
+11% +$21.7K 0.09% 76
2021
Q4 		$216K Buy
901
+23
+3% +$5.91K 0.1% 72
2021
Q3 		$248K Hold
878
– – 0.11% 57
2021
Q2 		$304K Buy
878
+22
+3% +$6.67K 0.14% 50
2021
Q1 		$239K Buy
+856
New +$231K 0.15% 51

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Auxano Advisors's BIIB Position: Q4 2024 in Review

Auxano Advisors sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,321 shares — an estimated $450K sold.

Auxano Advisors first reported a position in BIIB in Q1 2021 and held it in 15 quarters. The position peaked at $603K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Auxano Advisors reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Auxano Advisors sold 2,321 Biogen shares in Q4 2024, an estimated $450K.
  • Auxano Advisors first reported a position in Biogen in Q1 2021 and held it in 15 quarters.
  • Auxano Advisors's Biogen position peaked at $603K in Q2 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Auxano Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.